Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedMinor formatting and text edits were made across the study record; core trial details such as eligibility criteria, outcomes, and status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedThe Study Record Dates section now shows 'Last Update Posted (Estimated)' instead of 'Last Update Posted'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoChange DetectedThe study's Locations section was updated to show 59 sites across the US, Canada, and other regions. The Freiburg site (Universitatsklinikum Freiburg) was terminated, reducing the total number of locations.SummaryDifference2%

- Check23 days agoChange DetectedRecruitment status changed from Recruiting to Completed, with the update posted on 2025-12-05.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page update shows a new revision number (v3.3.2) without visible changes to the study details or related information.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.